Efficacy and risks of fondaparinux 7.5 mg for deep vein thrombosis after total knee arthroplasty

Efficacy and risks of fondaparinux 7.5 mg for deep vein thrombosis after total knee arthroplasty

Objectives: High-dose fondaparinux therapy at 7.5 mg/day (FPX 7.5 mg) for deep vein thrombosis (DVT) may increase the risk of hemorrhage. We investigated the efficacy and safety of FPX 7.5 mg to treat DVT after total knee arthroplasty. Methods: This study included 101 patients (91 with osteoarthriti...

Full description

Bibliographic Details
Main Authors: Sho Nojiri, Kazue Hayakawa, Hideki Date, Harumoto Yamada
Format: Article
Language:English
Published: Fujita Medical Society 2019-02-01
Series:Fujita Medical Journal
Subjects:
deep vein thrombosis
fondaparinux
pulmonary thromboembolism
total knee arthroplasty
Online Access:https://www.jstage.jst.go.jp/article/fmj/5/1/5_2017-020/_pdf/-char/en

Internet

https://www.jstage.jst.go.jp/article/fmj/5/1/5_2017-020/_pdf/-char/en

Similar Items